taxonomy (2)
protein (12)
source (8)
structure (67)
composition (54)
disease (1)
reference (11)
site (27)
peptide (0)
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-fetoprotein / Homo sapiens P02771
- Complement factor h / Homo sapiens P08603
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Kininogen-1 / Homo sapiens P01042
- Serotransferrin / Homo sapiens P02787
- Thrombospondin-1 / Homo sapiens P07996
- Vitronectin / Homo sapiens P04004
- Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus P08289
- Major membrane glycoprotein - MII2 / Rattus norvegicus
- Uncharacterized protein from Liver / Rattus norvegicus
Protein
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Liver (UBERON_0002107) AH66-TC (CVCL_4368) Plasma Membrane (GO_0005886)
- Liver (UBERON_0002107) BTI-Tn-5B1-4 (CVCL_C190)
- Liver (UBERON_0002107) H5 (CVCL_4212)
- Liver (UBERON_0002107) Hep-G2 (CVCL_0027)
- Liver (UBERON_0002107) Zajdela-Hepatoma (CVCL_1D00) Cell Surface (GO_0009986)
Source
- C-Linked / Undefined core / Man
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3532
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3041
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 3507
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 644
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3534
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 3232
- N-Linked / Complex / Neu?c(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu?c(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 720
- N-Linked / Complex / Structure 257
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)[Fuc(a1-?)]GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3126
- N-Linked / Complex / Structure 3528
- N-Linked / Complex / Structure 3627
- N-Linked / Complex / Structure 1814
- N-Linked / Complex / Structure 1991
- N-Linked / Complex / Structure 3629
- N-Linked / Complex / Structure 1437
- N-Linked / Complex / Structure 19
- N-Linked / Complex / Structure 2325
- N-Linked / Complex / Structure 452
- N-Linked / Complex / Structure 2448
- N-Linked / High-Mannose / Man(a1-3)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x Man(a1-2)"
- N-Linked / Hybrid / Structure 1224
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / Structure 20
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Structure 3567
- N-Linked / No-core / Man(a1-6)Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / No-core / Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- O-Linked / Core 0 / GalNAc
- O-Linked / Core 1 / Gal(b1-3)GalNAc
- O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)GalNAc
- O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GalNAc
- O-Linked / Core 2 / Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Gal(b1-3)GlcNAc(b1-6)[Gal(b1-3)]GalNAc
- O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc
- O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / No-core / Fuc
- O-Linked / No-core / Glc(?1-?)Fuc
Reported structure
- dHex:1 (avg mass : 164.1583 )
- HexNAc:1 (avg mass : 221.2103 )
- Hex:1 (avg mass : 180.1577 )
- Hex:1 dHex:1 (avg mass : 326.3007 )
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:1 HexNAc:2 (avg mass : 586.5477 )
- Hex:1 HexNAc:2 NeuAc:1 (avg mass : 877.8056 )
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:2 HexNAc:2 NeuAc:1 (avg mass : 1039.948 )
- Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
- Hex:2 HexNAc:2 dHex:1 (avg mass : 894.8331 )
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:4 HexNAc:2 (avg mass : 1072.9749 )
- Hex:4 HexNAc:2 dHex:1 (avg mass : 1219.1179 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:2 dHex:1 (avg mass : 1381.2603 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
- Hex:6 HexNAc:5 dHex:4 (avg mass : 2591.4167 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:2 (avg mass : 2664.4681 )
- Hex:7 HexNAc:6 dHex:3 (avg mass : 2810.6111 )
- Hex:7 HexNAc:6 dHex:4 (avg mass : 2956.7541 )
- Hex:7 HexNAc:6 dHex:5 (avg mass : 3102.8971 )
- Hex:7 HexNAc:6 dHex:6 (avg mass : 3249.0401 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
Composition
- Carcinoma, Hepatocellular (DOID:684)
Disease
- In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation (2014 - Hwang H, Lee JY, Lee HK, Park GW, Jeong HK, Moon MH, Kim JY, Yoo JS.) / Status : Reviewed
- Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins (2014 - Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R.) / Status : Reviewed
- C-mannosylation and O-fucosylation of the thrombospondin type 1 module. (2001 - Hofsteenge J, Huwiler K, Macek B, Hess D, Lawler J, Mosher D, Peter-Katalinic J) / Status : Reviewed
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Human alpha-fetoprotein produced from Hep G2 cell line: structure and heterogeneity of the oligosaccharide moiety. (1995 - Ferranti P, Pucci P, Marino G, Fiume I, Terrana B, Ceccarini C, Malorni A) / Status : Reviewed
- Alteration of asparagine-linked glycosylation in serum transferrin of patients with hepatocellular carcinoma. (1994 - Matsumoto K, Maeda Y, Kato S, Yuki H) / Status : Reviewed
- Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. (1993 - Saitoh A, Aoyagi Y, Asakura H) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
- Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy. (1990 - Terrana B, Tecce M, Manetti R, Ceccarini C, Lamba D, Segre A) / Status : Reviewed
- The structure of the O-glycosidic oligosaccharide chains of the major Zajdela hepatoma ascites-cell-membrane glycoprotein. (1986 - Nato F, Goulut C, Bourrillon R, Van Halbeek H, Vliegenthart J) / Status : Reviewed
- Structure of O-glycosidically linked sugar units from plasma membranes of an ascites hepatoma, AH 66. (1982 - Funakoshi I, Yamashina I) / Status : Reviewed
Reference
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
- Complement factor h / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
Serotransferrin / Homo sapiens
- Undefined site
- Thrombospondin-1 / Homo sapiens
- Vitronectin / Homo sapiens
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
Major membrane glycoprotein - MII2 / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
Reported glycosite
Mass spectrometry observed peptide
-
- C-Linked / Undefined core
(avg mass : 180.1577)
- Carcinoma, Hepatocellular (DOID:684)
-
Thrombospondin-1 / Homo sapiens
- Undefined site
- Trp-498
-
- N-Linked / Complex
(avg mass : 1463.3655)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1567.4278)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Complement factor h / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Carcinoma, Hepatocellular (DOID:684)
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Alteration of asparagine-linked glycosylation in serum transferrin of patients with hepatocellular carcinoma. (1994 - Matsumoto K, Maeda Y, Kato S, Yuki H) / Status : Reviewed
- Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. (1993 - Saitoh A, Aoyagi Y, Asakura H) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Serotransferrin / Homo sapiens
- Undefined site
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Carcinoma, Hepatocellular (DOID:684)
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Alteration of asparagine-linked glycosylation in serum transferrin of patients with hepatocellular carcinoma. (1994 - Matsumoto K, Maeda Y, Kato S, Yuki H) / Status : Reviewed
- Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. (1993 - Saitoh A, Aoyagi Y, Asakura H) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Serotransferrin / Homo sapiens
- Undefined site
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Complement factor h / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1844.7023)
- Carcinoma, Hepatocellular (DOID:684)
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Carcinoma, Hepatocellular (DOID:684)
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Alteration of asparagine-linked glycosylation in serum transferrin of patients with hepatocellular carcinoma. (1994 - Matsumoto K, Maeda Y, Kato S, Yuki H) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Serotransferrin / Homo sapiens
- Undefined site
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Complement factor h / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Carcinoma, Hepatocellular (DOID:684)
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Carcinoma, Hepatocellular (DOID:684)
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Complement factor h / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Liver (UBERON_0002107) Hep-G2 (CVCL_0027)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2299.1307)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Complement factor h / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Liver (UBERON_0002107) Hep-G2 (CVCL_0027)
- Carcinoma, Hepatocellular (DOID:684)
- Human alpha-fetoprotein produced from Hep G2 cell line: structure and heterogeneity of the oligosaccharide moiety. (1995 - Ferranti P, Pucci P, Marino G, Fiume I, Terrana B, Ceccarini C, Malorni A) / Status : Reviewed
- Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy. (1990 - Terrana B, Tecce M, Manetti R, Ceccarini C, Lamba D, Segre A) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2372.1821)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2372.1821)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2445.2737)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2516.3091)
- Liver (UBERON_0002107) Hep-G2 (CVCL_0027)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2518.3251)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2518.3251)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2591.4167)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2664.4681)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2735.5035)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2810.6111)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2880.6184)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2956.7541)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3026.7614)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3026.7614)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3102.8971)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3249.0401)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
- Haptoglobin / Homo sapiens
-
- N-Linked / High-Mannose
(avg mass : 1072.9749)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1219.1179)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1235.1173)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1381.2603)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1397.2597)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1559.4021)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1721.5445)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1883.6869)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1438.3123)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Hybrid
(avg mass : 1438.3123)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1584.4553)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1600.4547)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1729.5702)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / Hybrid
(avg mass : 1746.5977)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1891.7126)
- Blood Plasma (UBERON_0001969)
- Carcinoma, Hepatocellular (DOID:684)
- Vitronectin / Homo sapiens
-
- N-Linked / No-core
(avg mass : 748.6901)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / No-core
(avg mass : 894.8331)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Pauci-Mannose
(avg mass : 910.8325)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / Pauci-Mannose
(avg mass : 1056.9755)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 0
(avg mass : 221.2103)
- Carcinoma, Hepatocellular (DOID:684)
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 1
(avg mass : 383.3527)
- Carcinoma, Hepatocellular (DOID:684)
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 1
(avg mass : 674.6106)
- Liver (UBERON_0002107) AH66-TC (CVCL_4368) Plasma Membrane (GO_0005886)
- Liver (UBERON_0002107) Zajdela-Hepatoma (CVCL_1D00) Cell Surface (GO_0009986)
- Carcinoma, Hepatocellular (DOID:684)
- The structure of the O-glycosidic oligosaccharide chains of the major Zajdela hepatoma ascites-cell-membrane glycoprotein. (1986 - Nato F, Goulut C, Bourrillon R, Van Halbeek H, Vliegenthart J) / Status : Reviewed
- Structure of O-glycosidically linked sugar units from plasma membranes of an ascites hepatoma, AH 66. (1982 - Funakoshi I, Yamashina I) / Status : Reviewed
-
Major membrane glycoprotein - MII2 / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 1
(avg mass : 965.8685)
- Carcinoma, Hepatocellular (DOID:684)
-
Major membrane glycoprotein - MII2 / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 2
(avg mass : 586.5477)
- Carcinoma, Hepatocellular (DOID:684)
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 2
(avg mass : 748.6901)
- Carcinoma, Hepatocellular (DOID:684)
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 2
(avg mass : 877.8056)
- Carcinoma, Hepatocellular (DOID:684)
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1039.948)
- Liver (UBERON_0002107) AH66-TC (CVCL_4368) Plasma Membrane (GO_0005886)
- Liver (UBERON_0002107) Zajdela-Hepatoma (CVCL_1D00) Cell Surface (GO_0009986)
- Carcinoma, Hepatocellular (DOID:684)
- The structure of the O-glycosidic oligosaccharide chains of the major Zajdela hepatoma ascites-cell-membrane glycoprotein. (1986 - Nato F, Goulut C, Bourrillon R, Van Halbeek H, Vliegenthart J) / Status : Reviewed
- Structure of O-glycosidically linked sugar units from plasma membranes of an ascites hepatoma, AH 66. (1982 - Funakoshi I, Yamashina I) / Status : Reviewed
-
Major membrane glycoprotein - MII2 / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1039.948)
- Liver (UBERON_0002107) AH66-TC (CVCL_4368) Plasma Membrane (GO_0005886)
- Liver (UBERON_0002107) Zajdela-Hepatoma (CVCL_1D00) Cell Surface (GO_0009986)
- Carcinoma, Hepatocellular (DOID:684)
- The structure of the O-glycosidic oligosaccharide chains of the major Zajdela hepatoma ascites-cell-membrane glycoprotein. (1986 - Nato F, Goulut C, Bourrillon R, Van Halbeek H, Vliegenthart J) / Status : Reviewed
- Structure of O-glycosidically linked sugar units from plasma membranes of an ascites hepatoma, AH 66. (1982 - Funakoshi I, Yamashina I) / Status : Reviewed
-
Major membrane glycoprotein - MII2 / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1331.2059)
- Liver (UBERON_0002107) AH66-TC (CVCL_4368) Plasma Membrane (GO_0005886)
- Liver (UBERON_0002107) Zajdela-Hepatoma (CVCL_1D00) Cell Surface (GO_0009986)
- Carcinoma, Hepatocellular (DOID:684)
- The structure of the O-glycosidic oligosaccharide chains of the major Zajdela hepatoma ascites-cell-membrane glycoprotein. (1986 - Nato F, Goulut C, Bourrillon R, Van Halbeek H, Vliegenthart J) / Status : Reviewed
- Structure of O-glycosidically linked sugar units from plasma membranes of an ascites hepatoma, AH 66. (1982 - Funakoshi I, Yamashina I) / Status : Reviewed
-
Major membrane glycoprotein - MII2 / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Liver / Rattus norvegicus
- Undefined site
-
- O-Linked / No-core
(avg mass : 164.1583)
- Carcinoma, Hepatocellular (DOID:684)
-
Thrombospondin-1 / Homo sapiens
- Undefined site
- Thr-507
-
- O-Linked / No-core
(avg mass : 326.3007)
- Carcinoma, Hepatocellular (DOID:684)
-
Thrombospondin-1 / Homo sapiens
- Undefined site
- Thr-507
Disease
Reported glycosite
- O-Linked / No-core
(avg mass : 326.3007)
Disease
Reported glycosite
- O-Linked / No-core
(avg mass : 164.1583)
Source
Disease
Reference
Reported glycosite
- O-Linked / Core 2
(avg mass : 1331.2059)
Source
Disease
Reference
Reported glycosite
- O-Linked / Core 2
(avg mass : 1039.948)
Source
Disease
Reference
Reported glycosite
- O-Linked / Core 2
(avg mass : 1039.948)
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 877.8056)
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 748.6901)
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 586.5477)
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 965.8685)
Source
Disease
Reference
Reported glycosite
- O-Linked / Core 1
(avg mass : 674.6106)
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 383.3527)
Disease
Reported glycosite
- O-Linked / Core 0
(avg mass : 221.2103)
Source
Disease
Reported glycosite
- N-Linked / Pauci-Mannose
(avg mass : 1056.9755)
Source
Disease
Reported glycosite
- N-Linked / Pauci-Mannose
(avg mass : 910.8325)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 894.8331)
Source
Disease
Reported glycosite
- N-Linked / No-core
(avg mass : 748.6901)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1891.7126)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1746.5977)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1729.5702)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1600.4547)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1584.4553)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1438.3123)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1438.3123)
Source
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1883.6869)
Source
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1721.5445)
Source
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1559.4021)
Source
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1397.2597)
Source
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1381.2603)
Source
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1235.1173)
Source
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1219.1179)
Source
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1072.9749)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 3249.0401)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 3102.8971)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 3026.7614)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 3026.7614)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2956.7541)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2880.6184)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2810.6111)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2735.5035)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2664.4681)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2591.4167)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2518.3251)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2518.3251)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2516.3091)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2445.2737)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2372.1821)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2372.1821)
Source
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2299.1307)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1844.7023)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1567.4278)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1463.3655)
Disease
Reported glycosite
- C-Linked / Undefined core
(avg mass : 180.1577)